VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Vireo Growth Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026
- Market cap
- $406.23M
- P/E (TTM)
- –
- Dividend yield
- –
Vireo Growth Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Retail | $219.93M | $79.53M | $73.62M | $62.12M | $44.69M | $37.24M | 81.8% | +176.5% |
| Wholesale | $48.84M | $19.85M | $14.51M | $12.50M | $9.75M | $11.97M | 18.2% | +146.0% |
| Other | – | – | – | – | – | $2.71K | – | – |
By region
From the segment and revenue-disaggregation notes of Vireo Growth's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.